Key result
SARS-CoV-2 genomic analysis identifies 4 significant orf1ab mutations, mostly unique to the US.
Why the study?
Mutations in the SARS-CoV-2 orf1ab polyprotein, which plays a key role in viral RNA synthesis, require assessment to understand their impact on viral function and therapeutic design.
Observational (n=1,134)
Yes
Identified unique mutations in the SARS-CoV-2 orf1ab polyprotein in the US population, which may impact viral structure and function and inform antiviral therapeutic design.
Answers are grounded in this paper and cite their sources.
US-specific orf1ab mutations support variant surveillance; leaves open functional effects on replication or antiviral efficacy.
The pandemic COVID-19 outbreak has been caused due to SARS-CoV-2 pathogen, resulting in millions of infections and deaths worldwide, the United States being on top at the present moment. The long, complex orf1ab polyproteins of SARS-CoV-2 play an important role in viral RNA synthesis. To assess the impact of mutations in this important domain, we analyzed 1134 complete protein sequences of the orf1ab polyprotein from the NCBI virus database from affected patients across various states of the United States from December 2019 to 25 April 2020. Multiple sequence alignment using Clustal Omega followed by statistical significance was calculated. Four significant mutations T265I (nsp 2), P4715L (nsp 12), and P5828L and Y5865C (both at nsp 13) were identified in important nonstructural proteins, which function either as replicase or helicase. A comparative analysis shows 265 T→I, 5828 P→L, and 5865Y→C are unique to the United States and not reported from Europe or Asia; while one, 4715 P→L is predominant in both Europe and the United States. Mutational changes in amino acids are predicted to alter the structure and function of the corresponding proteins, thereby, it is imperative to consider the mutational spectra while designing new antiviral therapeutics targeting viral orf1ab.
No takes yet. Share an insight, caveat, or question.
Banerjee et al. (2020) conducted an observational in COVID-19 (SARS-CoV-2) (n=1,134). SARS-CoV-2 orf1ab polyprotein mutations was evaluated on Identification of significant mutations in the orf1ab polyprotein. Analysis of 1,134 SARS-CoV-2 orf1ab polyprotein sequences identified four significant mutations (T265I, P4715L, P5828L, Y5865C), three of which are unique to the United States.
Synapse has enriched 10 related papers. Consider them for comparative context: